Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Institut Curie
Seagen Inc.
Cedars-Sinai Medical Center
Sun Yat-sen University
US Oncology Research
Dana-Farber Cancer Institute
Novartis
UNC Lineberger Comprehensive Cancer Center
Duke University
OHSU Knight Cancer Institute
Novartis
Angiochem Inc
BBB-Therapeutics B.V.
GlaxoSmithKline
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)